116 related articles for article (PubMed ID: 38221655)
1. Impact of neoadjuvant therapy on nodal harvest in clinical stage III rectal cancer: Establishing optimum cut-offs by disease response.
Wehrle CJ; Woo K; Chang J; Gamaleldin M; DeHaan R; Dahdaleh F; Felder S; Rosen DR; Champagne B; Steele SR; Naffouje SA
J Surg Oncol; 2024 Apr; 129(5):945-952. PubMed ID: 38221655
[TBL] [Abstract][Full Text] [Related]
2. The ypT may better predict the efficacy of neoadjuvant chemoradiotherapy than tumor regression grade in locally advanced rectal cancer patients diagnosed ypT1-4N0.
Cui Y; Liu X; Li S; Wang H; Xiang Y; Zhang Y; Song M; Geng J; Liu Z; Teng H; Zhu X; Cai Y; Li Y; Wang W
Clin Transl Oncol; 2024 Apr; 26(4):1012-1021. PubMed ID: 38051436
[TBL] [Abstract][Full Text] [Related]
3. Magnetic resonance imaging for assessment of rectal cancer nodes after chemoradiotherapy: A single center experience.
Barbaro B; Carafa MRP; Minordi LM; Testa P; Tatulli G; Carano D; Fiorillo C; Chiloiro G; Romano A; Valentini V; Gambacorta MA
Radiother Oncol; 2024 Apr; 193():110124. PubMed ID: 38309586
[TBL] [Abstract][Full Text] [Related]
4. [Rectum-preserving surgery after consolidation neoadjuvant therapy or totally neoadjuvant therapy for low rectal cancer: a preliminary report].
Huang Y; Huang SH; Chi P; Wang XJ; Lin HM; Lu XR; Ye DX; Lin Y; Deng Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Mar; 23(3):281-288. PubMed ID: 32192308
[No Abstract] [Full Text] [Related]
5. Nodal Disease in Rectal Cancer Patients With Complete Tumor Response After Neoadjuvant Chemoradiation: Danger Below Calm Waters.
Baucom RB; Maguire LH; Kavalukas SL; Geiger TM; Ford MM; Muldoon RL; Hopkins MB; Hawkins AT
Dis Colon Rectum; 2017 Dec; 60(12):1260-1266. PubMed ID: 29112561
[TBL] [Abstract][Full Text] [Related]
6. The prognostic significance of the treatment response of regional lymph nodes and the refinement of the current TNM staging system in locally advanced rectal cancer after neoadjuvant chemoradiotherapy.
Cui J; Zhang L; Yang L; Zhu YL; Fang H; Chen B; Ning Y; Zhang HZ
Cancer Med; 2020 Dec; 9(24):9373-9384. PubMed ID: 33079470
[TBL] [Abstract][Full Text] [Related]
7. Retrospective Evaluation of the Efficacy of Total Neoadjuvant Therapy and Chemoradiotherapy Neoadjuvant Treatment in Relation to Surgery in Patients with Rectal Cancer.
Bratu LD; Schenker M; Stovicek PO; Schenker RA; Mehedințeanu AM; Berisha TC; Donoiu A; Mogoantă SȘ
Medicina (Kaunas); 2024 Apr; 60(4):. PubMed ID: 38674302
[No Abstract] [Full Text] [Related]
8. Lymph node regression after neoadjuvant chemoradiotherapy in rectal cancer.
Ozturk SK; Martinez CG; Mens D; Verhoef C; Tosetto M; Sheahan K; de Wilt JHW; Hospers GAP; van de Velde CJH; Marijnen CAM; van der Post RS; Nagtegaal ID
Histopathology; 2024 May; 84(6):935-946. PubMed ID: 38192084
[TBL] [Abstract][Full Text] [Related]
9. Response to chemoradiotherapy and lymph node involvement in locally advanced rectal cancer.
García-Flórez LJ; Gómez-Álvarez G; Frunza AM; Barneo-Serra L; Fresno-Forcelledo MF
World J Gastrointest Surg; 2015 Sep; 7(9):196-202. PubMed ID: 26425268
[TBL] [Abstract][Full Text] [Related]
10. Refining pathological evaluation of neoadjuvant therapy for adenocarcinoma of the esophagus.
Noble F; Nolan L; Bateman AC; Byrne JP; Kelly JJ; Bailey IS; Sharland DM; Rees CN; Iveson TJ; Underwood TJ; Bateman AR
World J Gastroenterol; 2013 Dec; 19(48):9282-93. PubMed ID: 24409055
[TBL] [Abstract][Full Text] [Related]
11. [Analysis on efficacy and safety of total neoadjuvant therapy in patients with locally advanced rectal cancer with high risk factors].
Ouyang GL; Meng WJ; Shu P; Deng XB; Wu B; Jiang D; Zhuang H; Shen YL; Zhou ZG; Wang ZQ; Wang X
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Apr; 22(4):349-356. PubMed ID: 31054549
[No Abstract] [Full Text] [Related]
12. The prognostic value of tumour regression grade following neoadjuvant chemoradiation therapy for rectal cancer.
Abdul-Jalil KI; Sheehan KM; Kehoe J; Cummins R; O'Grady A; McNamara DA; Deasy J; Breathnach O; Grogan L; O'Neill BD; Faul C; Parker I; Kay EW; Hennessy BT; Gillen P
Colorectal Dis; 2014 Jan; 16(1):O16-25. PubMed ID: 24119076
[TBL] [Abstract][Full Text] [Related]
13. Predictors of Pathologic Response After Total Neoadjuvant Therapy in Patients With Rectal Adenocarcinoma: A National Cancer Database Analysis.
McDermott DM; Singh SA; Renz PB; Hasan S; Weir J
Cureus; 2021 Aug; 13(8):e17233. PubMed ID: 34540460
[TBL] [Abstract][Full Text] [Related]
14. A Novel Tumor Staging System Incorporating Tumor Regression Grade (TRG) With Lymph Node Status (ypN-Category) Results in Better Prognostication Than ypTNM Stage Groups After Neoadjuvant Therapy for Esophageal Squamous Cell Carcinoma.
Wong IYH; Chung JCY; Zhang RQ; Gao X; Lam KO; Kwong DLW; Chao YK; Law SYK
Ann Surg; 2022 Nov; 276(5):784-791. PubMed ID: 35876374
[TBL] [Abstract][Full Text] [Related]
15. The combination of early treatment response and ypT stage is a novel metric to stage rectal cancer patients treated with neoadjuvant chemoradiotherapy.
Cui J; Yang L; Guo L; Shao Y; Tan D; Li N; Zhang H
Oncotarget; 2017 Jun; 8(23):37845-37854. PubMed ID: 28103579
[TBL] [Abstract][Full Text] [Related]
16. Tumor regression grade combined with post-therapy lymph node status: A novel independent prognostic factor for patients treated with neoadjuvant therapy followed by surgery in locally advanced gastroesophageal junction and gastric carcinoma.
Yin H; Yao Q; Xie Y; Niu D; Jiang W; Cao H; Feng X; Li Y; Li Y; Zhang X; Shen L; Chen Y
Cancer Med; 2023 Oct; 12(19):19633-19643. PubMed ID: 37749981
[TBL] [Abstract][Full Text] [Related]
17. [Comparison of short-term efficacy and perioperative safety between neoadjuvant therapy and total neoadjuvant therapy in patients with locally advanced rectal cancer].
Zhai ZW; Zhang KN; Wang C; Han JG; Ma HC; Wei GH; Yang Y; Wang ZJ
Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Mar; 23(3):274-280. PubMed ID: 32192307
[No Abstract] [Full Text] [Related]
18. Clinical impact of tumor regression grade after preoperative chemoradiation for locally advanced rectal cancer: subset analyses in lymph node negative patients.
Min BS; Kim NK; Pyo JY; Kim H; Seong J; Keum KC; Sohn SK; Cho CH
J Korean Soc Coloproctol; 2011 Feb; 27(1):31-40. PubMed ID: 21431095
[TBL] [Abstract][Full Text] [Related]
19. Can tumor regression grade influence survival outcome in ypT3 rectal cancer?
Shen L; Wang L; Li G; Zhang H; Liang L; Fan M; Wu Y; Deng W; Sheng W; Zhu J; Zhang Z
Clin Transl Oncol; 2016 Jul; 18(7):693-9. PubMed ID: 26527031
[TBL] [Abstract][Full Text] [Related]
20. Classification of pathologic response to neoadjuvant therapy in esophageal and junctional cancer: assessment of existing measures and proposal of a novel 3-point standard.
Donohoe CL; O'Farrell NJ; Grant T; King S; Clarke L; Muldoon C; Reynolds JV
Ann Surg; 2013 Nov; 258(5):784-92; discussion 792. PubMed ID: 24045450
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
